BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26345091)

  • 1. [5-(Benzyloxy)-1H-indol-1-yl]acetic acid, an aldose reductase inhibitor and PPARγ ligand.
    Soltesova Prnova M; Majekova M; Milackova I; Díez-Dacal B; Pérez-Sala D; Ceyhan MS; Banerjee S; Stefek M
    Acta Biochim Pol; 2015; 62(3):523-8. PubMed ID: 26345091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
    Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
    Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel aldose reductase inhibitors based on carboxymethylated mercaptotriazinoindole scaffold.
    Stefek M; Soltesova Prnova M; Majekova M; Rechlin C; Heine A; Klebe G
    J Med Chem; 2015 Mar; 58(6):2649-57. PubMed ID: 25695864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats.
    Djoubissie PO; Snirc V; Sotnikova R; Zurova J; Kyselova Z; Skalska S; Gajdosik A; Javorkova V; Vlkovicova J; Vrbjar N; Stefek M
    Gen Physiol Biophys; 2006 Dec; 25(4):415-25. PubMed ID: 17356233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: an aldose reductase inhibitor and antioxidant of zwitterionic nature.
    Stefek M; Tsantili-Kakoulidou A; Milackova I; Juskova M; Snirc V; Triantos N
    Bioorg Med Chem; 2011 Dec; 19(23):7181-5. PubMed ID: 22037047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Hydroxypyrazole as a bioisostere of the acetic acid moiety in a series of aldose reductase inhibitors.
    Papastavrou N; Chatzopoulou M; Pegklidou K; Nicolaou I
    Bioorg Med Chem; 2013 Sep; 21(17):4951-7. PubMed ID: 23891165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Novel Oxotriazinoindole Inhibitors of Aldose Reductase: Isosteric Sulfur/Oxygen Replacement in the Thioxotriazinoindole Cemtirestat Markedly Improved Inhibition Selectivity.
    Hlaváč M; Kováčiková L; Prnová MŠ; Šramel P; Addová G; Májeková M; Hanquet G; Boháč A; Štefek M
    J Med Chem; 2020 Jan; 63(1):369-381. PubMed ID: 31820975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent.
    Milackova I; Prnova MS; Majekova M; Sotnikova R; Stasko M; Kovacikova L; Banerjee S; Veverka M; Stefek M
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):107-13. PubMed ID: 24666303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly selective aldose reductase inhibitors. 3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
    Kotani T; Nagaki Y; Ishii A; Konishi Y; Yago H; Suehiro S; Okukado N; Okamoto K
    J Med Chem; 1997 Feb; 40(5):684-94. PubMed ID: 9057855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing acidity in a series of aldose reductase inhibitors: 2-Fluoro-4-(1H-pyrrol-1-yl)phenol as a scaffold for improved membrane permeation.
    Chatzopoulou M; Patsilinakos A; Vallianatou T; Prnova MS; Zakelj S; Ragno R; Stefek M; Kristl A; Tsantili-Kakoulidou A; Demopoulos VJ
    Bioorg Med Chem; 2014 Apr; 22(7):2194-207. PubMed ID: 24630695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications.
    Karasova MJ; Prnova MS; Stefek M
    Pharmazie; 2014 Oct; 69(10):747-51. PubMed ID: 25985564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
    Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B
    ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.
    Juskova M; Majekova M; Demopoulos V; Stefek M
    Gen Physiol Biophys; 2011 Dec; 30(4):342-9. PubMed ID: 22131315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure optimization of tetrahydropyridoindole-based aldose reductase inhibitors improved their efficacy and selectivity.
    Majekova M; Ballekova J; Prnova M; Stefek M
    Bioorg Med Chem; 2017 Dec; 25(24):6353-6360. PubMed ID: 29074349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxymethylated tetrahydropyridoindoles as aldose reductase inhibitors: in vitro selectivity study in intact rat erythrocytes in relation to glycolytic pathway.
    Juskova M; Snirc V; Gajdosikova A; Gajdosik A; Krizanova L; Stefek M
    Gen Physiol Biophys; 2009 Dec; 28(4):325-30. PubMed ID: 20097954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
    Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly selective aldose reductase inhibitors. 1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
    Ishii A; Kotani T; Nagaki Y; Shibayama Y; Toyomaki Y; Okukado N; Ienaga K; Okamoto K
    J Med Chem; 1996 Apr; 39(9):1924-7. PubMed ID: 8627616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic inhibition of aldose reductase.
    Kador PF; Sun G; Rait VK; Rodriguez L; Ma Y; Sugiyama K
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):373-81. PubMed ID: 11572468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.